Enhancing access to and diversity in cancer clinical trials through a financial reimbursement program: protocol to evaluate a novel program

DE Gerber, JA Tiro, LH McNeill, EL Williams… - Contemporary Clinical …, 2022 - Elsevier
As clinical trials have become more complex, with increasing numbers of required
procedures and clinic visits, gaining access to promising new treatments has become even …

A new approach to simplifying and harmonizing cancer clinical trials—Standardizing eligibility criteria

DE Gerber, H Singh, E Larkins, A Ferris… - JAMA …, 2022 - jamanetwork.com
Importance Clinical trial sponsors rely on eligibility criteria to control the characteristics of
patients in their studies, promote the safety of participants, and optimize the interpretation of …

Association of QT interval-prolonging drugs with clinical trial eligibility in patients with advanced cancer

EJ Rowe, T Shugg, RC Ly, S Philips… - Frontiers in …, 2022 - frontiersin.org
Introduction Drug-induced prolongation of the heart rate-corrected QT interval (QTc) is
associated with increased risk for the potentially fatal arrhythmia torsades de pointes. Due to …

[HTML][HTML] Standardizing eligibility criteria: a new approach to simplifying and harmonizing cancer clinical trials

DE Gerber, H Singh, E Larkins, A Ferris, PM Forde… - JAMA …, 2022 - ncbi.nlm.nih.gov
Objective: A LUNGevity Foundation working group developed a framework for lung cancer
clinical trial eligibility criteria. The goals of this framework are to (1) simplify eligibility …